Bias, spin, and misreporting: time for full access to trial protocols and results.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19067481.
- Also identified by DOI 10.1371/journal.pmed.0050230 and PMC identifier 2586359.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
An-Wen Chan discusses the implications of a new study in<i>PLoS Medicine</i> that suggests that the randomized trial literature is skewed towards reporting favorable results.
Medical subject headings
- Drug Approval
- Mandatory Reporting
- Publication Bias
- Randomized Controlled Trials as Topic
- United States Food and Drug Administration